Author
Listed:
- Monika Raab
(Goethe-University)
- Mourad Sanhaji
(Goethe-University)
- Yves Matthess
(Goethe-University
German Cancer Consortium (DKTK)/ German Cancer Research Center)
- Albrecht Hörlin
(Goethe-University)
- Ioana Lorenz
(Goethe-University)
- Christina Dötsch
(Goethe-University)
- Nils Habbe
(Goethe-University)
- Oliver Waidmann
(Goethe-University)
- Elisabeth Kurunci-Csacsko
(Goethe-University)
- Ron Firestein
(Centre for Cancer Research, Hudson Institute of Medical Research
Monash University)
- Sven Becker
(Goethe-University)
- Klaus Strebhardt
(Goethe-University
German Cancer Consortium (DKTK)/ German Cancer Research Center)
Abstract
The spindle assembly checkpoint (SAC) acts as a molecular safeguard in ensuring faithful chromosome transmission during mitosis, which is regulated by a complex interplay between phosphatases and kinases including PLK1. Adenomatous polyposis coli (APC) germline mutations cause aneuploidy and are responsible for familial adenomatous polyposis (FAP). Here we study the role of PLK1 in colon cancer cells with chromosomal instability promoted by APC truncation (APC-ΔC). The expression of APC-ΔC in colon cells reduces the accumulation of mitotic cells upon PLK1 inhibition, accelerates mitotic exit and increases the survival of cells with enhanced chromosomal abnormalities. The inhibition of PLK1 in mitotic, APC-∆C-expressing cells reduces the kinetochore levels of Aurora B and hampers the recruitment of SAC component suggesting a compromised mitotic checkpoint. Furthermore, Plk1 inhibition (RNAi, pharmacological compounds) promotes the development of adenomatous polyps in two independent Apc Min/+ mouse models. High PLK1 expression increases the survival of colon cancer patients expressing a truncated APC significantly.
Suggested Citation
Monika Raab & Mourad Sanhaji & Yves Matthess & Albrecht Hörlin & Ioana Lorenz & Christina Dötsch & Nils Habbe & Oliver Waidmann & Elisabeth Kurunci-Csacsko & Ron Firestein & Sven Becker & Klaus Strebh, 2018.
"PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells,"
Nature Communications, Nature, vol. 9(1), pages 1-17, December.
Handle:
RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03494-4
DOI: 10.1038/s41467-018-03494-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-03494-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.